Patents by Inventor Jimut Kanti Ghosh

Jimut Kanti Ghosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide inhibitors as novel anti-HIV therapeutics
    Patent number: 9327009
    Abstract: The present invention relates to synthetic peptide inhibitors (Seq ID No. 67-71) useful as anti-HIV therapeutics. The invention also relates to a novel screening method for screening anti-HIV molecules. The present invention relates to a synthetic peptide useful as anti-HIV therapeutic. The invention also relates to a novel screening method for screening of anti-HIV therapeutics. In particular, the present invention relates to reporter gene constructs for the detection of the HIV Nef and host ASK1 protein interaction. Furthermore, the invention relates to a functional interaction for Nef-ASK1 proteins prepared in a recombinant manner, a method for identifying of Nef-ASK1 interaction which causes activation of pathway to activate apoptosis presumably causing immune evasion for HIV in infected cells.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: May 3, 2016
    Assignee: Council of Scientific and Industrial Research
    Inventors: Raj Kamal Tripathi, Balawant Kumar, Ravishankar Ramachandran, Jitendra Kumar Tripathi, Smriti Bhadauria, Jimut Kanti Ghosh
  • PEPTIDE INHIBITORS AS NOVEL ANTI-HIV THERAPEUTICS
    Publication number: 20150182581
    Abstract: The present invention relates to synthetic peptide inhibitors (Seq ID No. 67-71) useful as anti-HIV therapeutics. The invention also relates to a novel screening method for screening anti-HIV molecules. The present invention relates to a synthetic peptide useful as anti-HIV therapeutic. The invention also relates to a novel screening method for screening of anti-HIV therapeutics. In particular, the present invention relates to reporter gene constructs for the detection of the HIV Nef and host ASK1 protein interaction. Furthermore, the invention relates to a functional interaction for Nef-ASK1 proteins prepared in a recombinant manner, a method for identifying of Nef-ASK1 interaction which causes activation of pathway to activate apoptosis presumably causing immune evasion for HIV in infected cells.
    Type: Application
    Filed: March 1, 2013
    Publication date: July 2, 2015
    Inventors: Raj Kamal Tripathi, Balawant Kumar, Ravishankar Ramachandran, Jitendra Kumar Tripathi, Smriti Bhadauria, Jimut Kanti Ghosh